Prevention and Treatment for Bruises in Patients With Ischemic Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 400 participants.

Also called NCT06823999

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 400 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06823999
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06823999. Randomized; quadruple masking; primary purpose treatment. Start 2025-08-01 (anticipated); primary completion 2028-07-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prevention and Treatment for Bruises in Patients With Ischemic Stroke
Condition
Stroke
Condition
Bruises
Condition
Skin Lesions
Intervention (Drug)
Ascorbic acid (Vitamin C)
Intervention (Other)
Normal Saline (Placebo)
Lead sponsor
Chiayi Christian Hospital (class: other)

Record details

Record id
cardio:ct-nct06823999
Content hash
356e6ff5b70f4ef782045921f53de7ba92732a4ec0eca2a019191193100986e0